Genomic Test Could Help Predict Aggressive Disease in Men Newly Diagnosed with Prostate Cancer
An analysis of patient data from across Michigan found scores from the Decipher Biopsy test independently aligned with outcomes
Randy Vince, Jr., M.D., M.S.
Newswise After a biopsy comes back positive for prostate cancer, patients and their doctors are often left with a choice between taking a watch-and-wait approach, known as active surveillance, or proceeding with surgery or radiation.
And identifying which patients will benefit from more immediate and aggressive treatment isn’t always clear.
A new, University of Michigan-led study analyzing data from more than 850 patients across the state of Michigan, however, found a commercially available genomic test known as Decipher Biopsy may help identify patients who are at high risk of cancer progression.
Genomic test could help predict aggressive disease in men newly diagnosed with prostate cancer
uofmhealth.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uofmhealth.org Daily Mail and Mail on Sunday newspapers.
Genomic test may help identify prostate cancer patients at high risk of disease progression
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Overcoming a newly recognized form of resistance to modern prostate cancer drugs
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
University of Michigan: Severe COVID cases likely to be followed by long-haul symptoms
Meredith Bruckner, Community News Producer, All About Ann Arbor
Published:
Tags:
Answering COVID vaccine questions: Will the vaccine help people with COVID long-haul symptoms? Does the vaccine make you contagious?
ANN ARBOR – People who become severely ill from COVID-19 are more likely to experience persistent symptoms, according to a new study by the University of Michigan.
Individuals who experience lingering symptoms long after their infection are known as long-haulers, and the findings underscore the critical need to identify and treat these patients.
Common long-haul symptoms, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC) include shortness of breath, extreme fatigue and continuous loss of smell or taste.